A detailed history of 21 West Wealth Management LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, 21 West Wealth Management LLC holds 359 shares of LLY stock, worth $294,157. This represents 0.26% of its overall portfolio holdings.

Number of Shares
359
Previous 372 3.49%
Holding current value
$294,157
Previous $290 Million 5.54%
% of portfolio
0.26%
Previous 0.29%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 14, 2025

SELL
$625.65 - $812.69 $8,133 - $10,564
-13 Reduced 3.49%
359 $274 Million
Q2 2025

Jul 08, 2025

BUY
$713.71 - $898.95 $265,500 - $334,409
372 New
372 $290 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $779B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track 21 West Wealth Management LLC Portfolio

Follow 21 West Wealth Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of 21 West Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on 21 West Wealth Management LLC with notifications on news.